bso glutathione inhibitor Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma investigate the effect of BSO on development of bovine embryos Sigma-Aldrich ᴅʟ-Buthionine-sulfoximine, CAS 5072-26-4, ≥99.0%
Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as Combination studies of platinum( ii ) based metallointercalators with buthionine S , R sulfoximine, 3 bromopyruvate, cisplatin or carboplatin Metallomics (RSC Publishing) DOI:10.1039 C3MT00191A The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



